PUBLICATIONS
P. P. Scaglioni and P. P. Pandolfi. Taking apart a
cancer protein. Nature. 2003. 426: 512-13.
C. Gurrieri, P. Capodieci, R. Bernardi, P. P. Scaglioni,
K. Nafa, L.J. Rush, D.A. Verbel, C. Cordon-Cardo, P. P. Pandolfi. Loss of the tumor
suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 2004.
96: 269-79.
R. Bernardi, P. P. Scaglioni, S. Bergmann, H.F. Horn,
K. H. Vousden and P. P. Pandolfi PML regulates p53 stability through nucleolar sequestration
of Mdm2. Nat. Cell. Biol. 2004. 6:665-672.
P. P. Scaglioni and P.P. Pandolfi. The theory of APL revisited.
Acute Promyelocytic Leukemia: Molecular Genetics, Mouse Models and Targeted Therapy. Current
Topics in Microbiology and Immunology. 2006. 313: 85-100.
H. Matsushita, P. P. Scaglioni, M. Bhaumik, E.M. Rego, L.F. Cai,
Hayato Miyachi, A. Kakizuka, W.H. Miller, P.P. Pandolfi. In vivo analysis of the role of
aberrant histone deacetylase recruitment and RARalpha blockade in the pathogenesis of acute
promyelocytic leukemia. J Exp Med. 2006. 17:821-828.
L.C. Trotman, A. Alimonti, P. P. Scaglioni, J.A. Koutcher, C.
Cordon-Cardo, P.P. Pandolfi. Identification of a tumour suppressor network opposing nuclear
Akt function. Nature. 2006. 25:523-527.
P. P Scaglioni, T. Yung, L. F. Cai, H. Erdjument-Bromage, P.
Tempst, J. Teruya-Feldstein, P. P. Pandolfi. A CK2-dependent pathway for PML degradation
upon cellular and oncogenic stress. Cell. 2006. 126:269-283.
T.H. Shen, H.K. Lin, P. P. Scaglioni, T.M. Yung, P. P. Pandolfi.
The Mechanisms of PML-Nuclear Body Formation. Mol Cell. 2006. 24:331-9.
P. P. Scaglioni, T.M. Yung, S.C. Choi, C.Baldini, G.
Konstantinidou, P.P. Pandolfi. CK2 mediates phosphorylation and ubiquitin-mediated
degradation of the PML tumor suppressor. Mol Cell Biochem. 2008. 316:149-54.
|
